R805W
Category 4 — Stable Fold, Function DisruptedConflictingLumenal · predictedσ-1 candidateEditorialArginine → Tryptophan at position 805 in lumenal domain. ClinVar Conflicting. AlphaMissense 0.487 (borderline), ΔΔG +0.26 STABILISING. R→W class — aromatic replaces charge.
Interactive 3D Structure
Bond changes · DynaMut2 interaction analysis
| Interaction type | Wild-type partner | Mutant partner | Status |
|---|---|---|---|
| Ionic bond | E776 | — | Lost |
| Hydrogen bond | F775 | F775 | Preserved |
| Hydrogen bond | — | E776 | Gained |
| Hydrogen bond | F840 | F840 | Preserved |
| Hydrogen bond | E841 | E841 | Preserved |
| Hydrogen bond | L842 | L842 | Preserved |
| Polar contact | F775 | F775 | Preserved |
| Polar contact | E776 | E776 | Preserved |
| Polar contact | F840 | F840 | Preserved |
| Polar contact | L842 | L842 | Preserved |
| Van der Waals | — | E776 | Gained |
| Van der Waals | — | V839 | Gained |
| Hydrophobic | E776 | E776 | Preserved |
| Hydrophobic | V839 | V839 | Preserved |
Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.
Computational Predictions
Clinical Evidence
Observed at very low frequency in gnomAD.
Structural Context
Position 805 in lumenal domain. Neighbors: ALA806 (2.4 Å — A806P), LEU804 (2.5 Å — L804P!), PHE775 (3.4 Å — F775V!), PHE840 (3.7 Å).
R805 sits in the dense 804-806 cluster (with L804P, A806P) and contacts F775 (F775V). Replacing R805 with tryptophan eliminates the positive charge and creates a tryptophan-phenylalanine aromatic cluster with F775 + F840. The variant fold packs efficiently (+0.26).
AM 0.487 borderline; ClinVar Conflicting. The mechanism is loss of R805 charge from the F775-R805 ionic/cation-π contact discussed in F775V Atlas card.
Druggability Assessment
Mechanism: loss of R805 cation-π contribution to F775 contact. Therapeutic: same 775-806 microregion (with L804P, A806P, F775V).
Why this matters
Feed this card to Wolfram Intelligence
Download the R805W PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.